Nanotechnology Drug Delivery Market in the US 2012-2016

Nanotechnology Drug Delivery Market in the US 2012-2016

Category : Healthcare

TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Nanotechnology Drug Delivery market in the US to grow at a CAGR of 84.79 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Nanotechnology Drug Delivery market in the US has also been witnessing the trend of emergence of personalized medicines. However, the increasing safety concerns could pose a challenge to the growth of this market. 
TechNavio's report, the Nanotechnology Drug Delivery Market in the US 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. It also covers the Nanotechnology Drug Delivery market in the US landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space include Alkermes plc.,Celgene Corp., Novartis AG and SkyePharma plc .
Other vendors mentioned in the report are Merck & Co. Inc., Pfizer Inc., AlphaRx Inc., Amgen, Inc., Angiotech Pharmaceuticals, Inc., Biophan Technologies, Inc., Calando Pharmaceuticals, Inc., Cephalon, Inc., Cerulean Pharma, Inc, Copernicus Therapeutics, Inc., CritiTech, Inc., CytImmune Sciences, Inc., Elan Corporation, plc, Debiotech SA, F. Hoffmann-La Roche Ltd, Nano Interface Technology, Inc, Spherics, Inc., Spectrum Pharmaceuticals, Inc., SoluBest Ltd., Sigma-Tau Pharmaceuticals, Inc., PharmaNova Inc. Particle Sciences, Inc., Novavax, Inc., Nanotherapeutics, Inc., NanoSight Ltd., NanoCarrier Co. Ltd., NanoBioMagnetics, Inc., Nano Interface Technology, Inc, Merck Sharp & Dohme Corp., Kuecept Ltd., Izon Science Ltd.
Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Scope of the Report


Market Overview

05. Market Landscape

05.1Nanotechnology Drug Delivery Market in the US

       Market Size and Forecast

05.2Global Nanotechnology Drug Delivery Market Segmentation

       05.3Five Force Analysis

06. Vendor Landscape

07. Buying Criteria

08. Market Growth Drivers

09. Drivers and their Impact

10. Market Challenges

11. Impact of Drivers and Challenges

12. Market Trends

13. Key Vendor Analysis


13.1 Alkermes plc

Business Overview

Key Information

SWOT Analysis

       13.2 Celgene Corp. 

               Business Overview 

               Key Information

 SWOT Analysis

      13.3 SkyePharma plc

               Business Overview

               SWOT Analysis

      13.4 Novartis AG

               Business Overview 

               Key Information

 SWOT Analysis

14. Other Reports in this Series 



List of Exhibits:



Exhibit 1:  Nanotechnology Drug Delivery Market in the US 2012-2016(US$ million)

Exhibit 2:  Global Nanotechnology Drug Delivery Market Segmentation by Technology

Exhibit 3: Global Nanotechnology Drug Delivery Market Segmentation 2012(percent)


Enquiry Before Buy
image
Can´t read the image ? refresh here.